Agenda

Session 1 - Mitral Valve Disease - A Primer for an Ever-Changing Landscape
Moderators – Tarek Malas, MD and Rhonda Miyasaka, MD

Case Presentation:
Rhonda Miyasaka, MD

Case Responses:

1. Guideline directed management of mitral valve disease: When, why and how to intervene
   Milind Desai, MD, MBA
2. Imaging of the mitral valve: the ABCs - Echo vs. TEE vs. Stress Echo
   L. Leonardo Rodriguez, MD
3. Role of advanced imaging (CT and MRI) in screening/workup of the mitral valve patient to the OR and the cath lab
   Serge Harb, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Case Presentation
L. Leonardo Rodriguez, MD

Case Responses:

1. Imaging considerations during TEER and surgery
   Rhonda Miyasaka, MD
   
2. Interventional cardiologist: TEER
   Samir Kapadia, MD
3. Surgeon: I can do a low risk robotic mitral valve repair
   Per Wierup, MD, PhD
4. Clinical cardiologist: Watchful waiting is all that’s needed
   Brian Griffin, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 2 - Management of Tricuspid Valve Disease
Moderators – Bernard Prendergast, DM, FRCP, FESC, and Per Wierup, MD, PhD

Lectures:
The natural history of tricuspid regurgitation
Milind Desai, MD, MBA

Tricuspid valve imaging: Considerations for assessment
Rhonda Miyasaka, MD

Case Presentation
Serge Harb, MD

Case Responses

1. Cardiology: Work up of a patient with TR. What is the current data on risk stratification?
   Milind Desai, MD, MBA
2. Addressing the tricuspid valve during mitral valve surgery: Any benefit?
   Tarek Malas, MD
3. 3.Interventionalist: Edge to edge TVR or tricuspid valve replacement
   Amar Krishnaswamy, MD
4. The EP physician as a member of the TR heart team
   Oussama Wazni, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 3 - Ventricular Arrhythmias and MR
Moderators - Brian Griffin, MD, and Pasquale Santangelli, MD, PhD

Lecture:
Mitral regurgitation and ventricular arrhythmias – risky business?
L. Leonardo Rodriguez, MD

Case Presentation:
Brian Griffin, MD

Case Responses:

1. Can I follow safely without intervention and how should I investigate this patient? Risk stratification: Which patient warrants early primary prevention
   Brian Griffin, MD
2. EP approach: antiarrhythmics, ablation or ICD?
   Pasquale Santangeli, MD, PhD
3. Surgical: Barlow’s valve repair
   Lars G. Svensson, MD, PhD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 4 - Atrial Arrhythmias and MR
Moderators – Stephanie Mick, MD, and Oussama Wazni, MD

Lecture:

Defining atrial functional MR: Pathophysiology
L. Leonardo Rodriguez, MD

Case Presentation:
Serge Harb, MD

Case Responses:

1. Imaging Assessment
   Rhonda Miyasaka, MD
2. EP approach: Antiarrhythmic, ablation, Watchman
   Oussama Wazni, MD
3. Surgical perspective: The role of surgery in atrial functional MR
   Stephanie Mick, MD
4. A role for TEER?
   Samir Kapadia, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 5 - TEER: State of the Art
Moderators – Samir Kapadia, MD, and Grant Reed, MD

Lecture:
What are the outcomes to date: Registry data from ACC and STS
Samir Kapadia, MD

Case Presentation:
Grant Reed, MD

Case Responses:

1. Cardiologist/How I assess the patient/The key role of imaging
   Brian Griffin, MD
2. Interventionalist: Tips and tricks for planning and execution - How to reduce failures and maximize durability
   Amar Krishnaswamy, MD
3. PRIMARY and REPAIR MR Trials
   Tarek Malas, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 6 - Ischemic MR
Moderators – Bernard Prendergast, DM, FRCP, FESC, and Per Wierup, MD, PhD

Lecture:
Challenges and limitations of current management and technology
Tarek Malas, MD

Case Presentation:
Brian Griffin, MD

Case Responses:

1. Clinical cardiologist: What is guideline-directed medical therapy in ischemic MR and is it enough?
   Brian Griffin, MD
2. EP Cardiologist: How to maximize roles of CRT and ICD on secondary MR to prevent or delay intervention
   Thomas Callahan, IV
3. Surgeon: Surgery for severe ischemic MR
   Tarek Malas, MD
4. Interventional management of severe ischemic MR
   Grant Reed, MD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 7 - Torrential Tricuspid Regurgitation
Moderators – Samir Kapadia, MD and Tarek Malas, MD

Lecture:

The future of transcatheter tricuspid intervention: Lessons from the trials and remaining unmet need in technology
Samir Kapadia, MD

Case Presentation:
Rhonda Miyasaka, MD

Case Responses:

1. Patient selection in TR: Predictors of success from multimodality imaging
   Serge Harb, MD
2. Replacement: Goal is total TR resolution
   Per Wierup, MD, PhD
3. Repair: Risk of replacement is too high
   Bernard Prendergast, DM, FRCP, FESC
4. PPM/ICD options in patients follow TR Interventions
   Thomas Callahan, IV

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 8 - HOCM: When and How to Address the Mitral Valve
Moderators – Milind Desai, MD, MBA, and Per Wierup, MD, PhD

Case Presentation:
Milind Desai, MD, MBA

Case Responses:

1. Interventional strategies in HOCM
   Amar Krishnaswamy, MD
2. Medical management - What’s new?
   Milind Desai, MD, MBA
3. Surgeon: Myectomy +/- Mitral
   Per Wierup, MD, PhD

What happened to the patient, panel discussion and attendee Q&A
Session faculty

Session 9 – Case-Based Management Approaches to Complex Scenarios
All talks in this session are 10 minutes
Moderators – Amar Krishnaswamy, MD, and Grant Reed, MD

Critical care management in the setting of Acute Decompensated Valvular Heart Disease
Grant Reed, MD

Severe mitral regurgitation after TEER – When and how to intervene in persistent or recurrent symptoms after intervention - what next?
Per Wierup, MD, PhD

Mitral valve dysfunction with underlying calcification including MAC
Tarek Malas, MD

Percutaneous valve in MAC
Samir Kapadia, MD

CIED lead management in tricuspid valve intervention
Thomas Callahan, IV